Skip to main content
. 2021 Jul 20;27(20):5576–5585. doi: 10.1158/1078-0432.CCR-21-1083

Figure 2.

Figure 2. RNA positivity (BM and PB) at diagnosis and clinical outcome (A) EFS and (B) OS for SR and RNA panel (C) EFS and (D) OS for patients stratified for PCR testing of BM and PB at diagnosis: negative in PB and BM (PB and BM−), PB positive only (only PB+), BM positive only (only BM+), and positive in PB and BM (PB and BM+). E, Venn diagram depicting number of patients that tested positive with the RNA panel in PB, BM, and by conventional IHC in BM at diagnosis. F, Venn diagram depicting patients that tested positive for PB and/or BM with the RNA panel and patients with metastatic disease, detected by conventional diagnostics at diagnosis.

RNA positivity (BM and PB) at diagnosis and clinical outcome (A) EFS and (B) OS for SR and RNA panel (C) EFS and (D) OS for patients stratified for PCR testing of BM and PB at diagnosis: negative in PB and BM (PB and BM−), PB positive only (only PB+), BM positive only (only BM+), and positive in PB and BM (PB and BM+). E, Venn diagram depicting number of patients that tested positive with the RNA panel in PB, BM, and by conventional IHC in BM at diagnosis. F, Venn diagram depicting patients that tested positive for PB and/or BM with the RNA panel and patients with metastatic disease, detected by conventional diagnostics at diagnosis.